Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Antivir Ther ; 10(2): 263-75, 2005.
Article in English | MEDLINE | ID: mdl-15865221

ABSTRACT

Severe acute respiratory syndrome (SARS), caused by a novel coronavirus, emerged in early 2003 as a major international health crisis. We report on serum cytokine levels, viral load and clinical parameters over the course of the disease in a cohort of nine adult SARS patients treated with steroids and interferon alfacon-1 at North York General Hospital in Toronto, Ontario. Considerable variation among SARS patients with respect to circulating viral load and patterns of SARS-CoV-evoked cytokine responses was recorded. No single cytokine profile was observed in all patients, yet serum concentrations of interferon (IFN)-gamma, interleukin (IL)-10, CXCL10, CCL5 and CXCL8 were found to be elevated above normal levels during the course of the disease in all patients. Expression levels for IL-10, IFN-gamma and CXCL10 consistently peaked within 4 days of peak viral load. IL-12p70, IL-4 and tumour necrosis factor-alpha concentrations were consistently highest within 5 days of peak viral load. These results suggest that elevated levels of inflammatory cytokines are sensitive correlates of disease severity, including lung abnormalities and viral load in serum, and may provide a tool for monitoring disease progression in affected individuals.


Subject(s)
Adrenal Cortex Hormones/therapeutic use , Antiviral Agents/therapeutic use , Glucocorticoids/therapeutic use , Interferon Type I/therapeutic use , Severe Acute Respiratory Syndrome/drug therapy , Administration, Oral , Adult , Chemokine CCL5 , Chemokine CXCL10 , Chemokines, CC/blood , Chemokines, CXC/blood , Cohort Studies , Cytokines/blood , Disease Progression , Drug Therapy, Combination , Female , Humans , Injections, Intravenous , Interferon-alpha , Interferon-gamma/blood , Male , Methylprednisolone/therapeutic use , Middle Aged , Prednisone/therapeutic use , Recombinant Proteins , Severe Acute Respiratory Syndrome/immunology , Severe Acute Respiratory Syndrome/pathology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...